News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Daily News Genetic Testing for CVD in Children: AHA Statement Suggests Focus on Multidisciplinary Care Yael L. Maxwell September 01, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2021 Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD Michael O'Riordan August 28, 2021
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Daily News ESC 2021 Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI Caitlin E. Cox August 26, 2021
News Daily News Global CTO Crossing Algorithm Seeks to Standardize Procedure Yael L. Maxwell August 18, 2021
News Daily News Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data Caitlin E. Cox August 16, 2021
News Daily News Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions Caitlin E. Cox August 10, 2021
News Conference News HRS 2021 Catheter Ablation ‘Good Value’ in CABANA Economic Analysis Michael O'Riordan August 04, 2021
News Conference News HRS 2021 Progestin OCs Triple CV Events in Women With Congenital Long QT Caitlin E. Cox July 30, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021